Skip to main content

Day: June 17, 2020

California Bank of Commerce Expands Sponsor Finance Division

OAKLAND, Calif., June 17, 2020 (GLOBE NEWSWIRE) — California Bank of Commerce (CBC) is expanding its Sponsor Finance Lending Division with the addition of veteran banker Marina Kremer. The division works closely with private equity firms (including Search Funds), SBICs and direct lenders to provide cash flow-based senior debt financing.“We’re pleased to announce and excited to have Marina join our team,” said Larry LaCroix, Executive Vice President and Manager of the Sponsor Finance Division. “Her vast banking experience in relationship and portfolio management adds depth to the Sponsor Finance group and will allow the division to continue its growth.”Kremer has served in various capacities in banking, most recently as Director of Credit/Underwriting at Neptune Financial (NepFin). Prior to NepFin, she worked at Bank of the West...

Continue reading

Finanssivalvonta on hyväksynyt United Bankers Oyj:n listalleottoesitteen

United Bankers OyjSISÄPIIRITIETO 17.6.2020 klo 15:35Finanssivalvonta on hyväksynyt United Bankers Oyj:n listalleottoesitteenFinanssivalvonta on tänään 17.6.2020 hyväksynyt United Bankers Oyj:n (”Yhtiö”) listalleottoesitteen (”Esite”), joka liittyy Yhtiön siirtymiseen Nasdaq First North Growth Market Finland -markkinapaikalta Nasdaq Helsingin pörssilistalle.Esite on saatavilla sähköisenä Yhtiön verkkosivustolta osoitteesta www.unitedbankers.fi/fi/oyj/sijoittajat/listautuminen ja paperikopiona Nasdaq Helsingistä osoitteesta Fabianinkatu 14, 00100 Helsinki arviolta 18.6.2020 alkaen. Lisäksi Esite on pyydettäessä saatavilla paperikopiona Yhtiön toimipaikasta osoitteesta Aleksanterinkatu 21 A, 00100 Helsinki.Yhtiö jätti 11.6.2020 hakemuksen Yhtiön A-osakkeiden ottamiseksi kaupankäynnin kohteeksi Nasdaq Helsingin pörssilistalle. Kaupankäynnin...

Continue reading

PDS Biotechnology and Farmacore Biotechnology Announce Co-Development of PDS0204 COVID-19 Vaccine

Brazilian government to provide initial funding support to progress development of Versamune®-based vaccine to prevent COVID-19 infectionFLORHAM PARK, N.J., June 17, 2020 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, today announced a co-development agreement with Farmacore Biotechnology for Versamune®-CoV-2FC, a Versamune®-based vaccine aimed at preventing COVID-19 infection.Under the collaboration, PDS Biotech and Farmacore will accelerate development of Versamune®-CoV-2FC into Phase 1 clinical testing in Brazil, with initial financial support provided by the Brazilian Ministry of Science, Technology, Innovation and Communication...

Continue reading

OZSC: Power Conversion Technologies, Inc. – Issues Bid For Global Defense Contractor

WARWICK, NY., June 17, 2020 (GLOBE NEWSWIRE) — Ozop Surgical Corp. (OTCPK: OZSC), (“Ozop” or the “Company”), today announced that Power Conversion Technologies, Inc. (“PCTI”), has submitted a sole source bid to one of the world’s largest defense contractors for multiple power converter units to be used in naval automatic weapons systems.“Our reputation is built on our ability to meet the exacting standards of mission-critical systems when other vendors cannot,” said PCTI President Catherine Chis. “We’re happy that this defense contractor has again turned to us for an innovative custom solution for this unique application.”PCTI is recognized in the industry as having a breadth of knowledge and expertise in the field of power conversion and management systems. Global players seek out PCTI for projects especially where no readily available...

Continue reading

Sortis Holdings Announces its Growth Fund Enters Into Deal with Happier Camper

Portland, Oregon, June 17, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Sortis Holdings Inc. (SOHI), a Portland, Oregon-based alternative investment firm, is proud to announce the Sortis Growth Fund has made an investment into Happier Camper, Inc., a leader in the rapidly growing category of compact and flexible campers. Since launching in 2016, Happier Camper has demonstrated the ability to design, market, and build community around their products. As part of the recently launched Sortis Growth Fund I, the targeted investment will focus on enhancing Happier Camper’s e-Commerce and Direct to Consumer platform, including a consumer financing option and a custom digital configuration tool. The Sortis Growth Fund accelerates emerging consumer brands in the next phase of growth by providing an infusion of capital and a digital strategy...

Continue reading

Yield10 Bioscience Begins 2020 Field Test Program to Evaluate Novel Yield Traits in Camelina and Canola

WOBURN, Mass., June 17, 2020 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced it has begun its 2020 Field Test Program based on the recent completion of planting at all sites contracted for the trials in the United States and Canada. Yield10’s 2020 Field Test Program is designed to evaluate several novel traits in Camelina and canola and the Company expects to harvest the plants and begin reporting data from the field tests in the fourth quarter of 2020.“We are pleased to report that our field trial contractors completed planting at all of the sites planned for our 2020 Field Test Program,” said Dr. Kristi Snell, Ph.D., Chief Science Officer of Yield10 Bioscience. “Our team will continue to work closely with our field trial contractors as well as local consultants to...

Continue reading

The Alkaline Water Company Achieves Record Fourth Quarter With Over 50% Growth

SCOTTSDALE, Ariz., June 17, 2020 (GLOBE NEWSWIRE) — The Alkaline Water Company Inc. (NASDAQ and CSE: WTER) (the “Company”), is a producer of premium bottled alkaline water, flavored-infused waters, and CBD infused products sold under the brand names Alkaline88®, A88 Infused™, and A88CBD™, respectively. The Company today announces the following fiscal fourth-quarter financial highlights:Fiscal Q4 Revenue Highlights (Unaudited): (All amounts are in U.S. dollars)Revenue of approximately $12.0 million –  up 51% over the prior yearRepresents revenue growth of 42% over fiscal Q3“This quarter’s results are a great way for our Company to end our fiscal year. We now have tremendous momentum going into fiscal 2021. We expect our first quarter ending June 30, 2020, to set another revenue record. The current pandemic acted as a catalyst...

Continue reading

Plato Gold Corp. Announces Increased Size of Non-Brokered Private Placement and Final Closing for $153,500

NOT FOR DISSEMINATION IN THE UNITED STATES OR OVER UNITED STATES NEWSWIRE SERVICESTORONTO, June 17, 2020 (GLOBE NEWSWIRE) — Plato Gold Corp. (TSX-V: PGC) (“Plato” or the “Corporation”) is pleased to announce that further to its news release dated May 21, 2020, it has increased and completed a non-brokered private placement (the “Offering”) of 3,069,990 common shares (“Shares”) at a price of CAN$0.05 per Share for gross proceeds of $153,500.The securities issued pursuant to the Offering will be subject to a four month and one day statutory hold period.The Corporation intends to use the net proceeds from the Offering on exploration to advance the Good Hope Niobium Property, the Pic River PGM Project, and for general working capital purposes.The participation in the Offering by Greg Wong, James Cohen, and Anthony Cohen are “related...

Continue reading

Husky Energy Reports Results of Series 7 Preferred Share Conversion

CALGARY, Alberta, June 17, 2020 (GLOBE NEWSWIRE) — Husky Energy (TSX: HSE) announces that 212,461 Cumulative Redeemable Preferred Shares, Series 7 (Series 7 Shares) were tendered for conversion, which is less than the one million shares required to give effect to conversion into Cumulative Redeemable Preferred Shares, Series 8 (Series 8 Shares). As a result, none of the Series 7 Shares will be converted into Series 8 Shares on June 30, 2020.Investor and Media Inquiries:Leo Villegas, Senior Manager, Investor Relations403-513-7817Kim Guttormson, Manager, Communication Services403-298-7088

Continue reading

New Collaboration with Bethyl Laboratories Expands Antibody Offerings for Hyperion Imaging System

Fluidigm to Be Exclusive Distributor for Bethyl Antibodies for Use with Imaging Mass CytometryProviding Researchers with Expanded Capabilities in Interrogating the Tissue MicroenvironmentSOUTH SAN FRANCISCO, Calif., June 17, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a collaboration with Bethyl Laboratories to provide broader verified antibody access for researchers using Fluidigm’s Imaging Mass Cytometry™ (IMC™) technology.“Tools for understanding the immune system are more important than ever as researchers work to improve human health, particularly in responding to challenges posed by COVID‑19,” said Andrew Quong, PhD, Chief Science Officer of Fluidigm. “With Bethyl’s leadership in specialized...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.